CITIUS PHARMACEUTICALS INC's ticker is and the CUSIP is 17322U907. A total of 2 filers reported holding CITIUS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $31 | -86.4% | 46,000 | -75.8% | 0.00% | – |
Q2 2023 | $228 | +15.2% | 190,400 | +12.4% | 0.00% | – |
Q1 2023 | $198 | -16.1% | 169,400 | -43.4% | 0.00% | – |
Q4 2022 | $236 | -99.9% | 299,400 | -4.8% | 0.00% | – |
Q3 2022 | $380,000 | +127.5% | 314,600 | +73.1% | 0.00% | – |
Q2 2022 | $167,000 | -49.5% | 181,700 | -2.0% | 0.00% | – |
Q1 2022 | $331,000 | +372.9% | 185,400 | +303.0% | 0.00% | – |
Q4 2021 | $70,000 | +3400.0% | 46,000 | +5011.1% | 0.00% | – |
Q3 2021 | $2,000 | – | 900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SIMPLEX TRADING, LLC | 46,000 | $70,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |